Exploring Biomarkers for Ankylosing Spondylitis
Author Information
Author(s): Ni Yuanpiao, Zhong Linrui, Li Yanhui, Zhang Zeng, Ming Bin, Qing Yufeng, Zhang Quanbo
Primary Institution: Affiliated Hospital of North Sichuan Medical College
Hypothesis
This study aims to identify new molecular biomarkers for ankylosing spondylitis (AS) through transcriptomic analysis.
Conclusion
The study identified five key genes associated with ankylosing spondylitis that may serve as potential biomarkers for diagnosis and treatment.
Supporting Evidence
- Six genes were identified through weighted gene co-expression network analysis.
- Five key genes were determined using LASSO regression with an AUC greater than 0.7.
- Key genes showed significant correlations with clinical indicators like hsCRP and ESR.
Takeaway
Researchers found important genes that can help doctors diagnose a disease called ankylosing spondylitis, which affects the spine.
Methodology
The study used gene expression data from two datasets, identified key genes through differential expression analysis and LASSO regression, and validated findings with RT-qPCR.
Potential Biases
Potential biases may arise from the reliance on gene expression data from peripheral blood mononuclear cells, which may not fully capture the disease's pathology.
Limitations
The study's small sample size may limit the generalizability of the results.
Participant Demographics
24 drug-naive patients with AS and 24 healthy male volunteers were included.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website